Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
43 results
D3.48 - The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital
D3.53 - A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre
D3.55 - Synthetic folic acid allergy
D3.47 - Implementing Penicillin Delabelling in an Inpatient setting
D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
D3.51 - Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists
D3.54 - Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
D3.56 - Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
D3.57 - Isoniazid-Induced Lupus in a Filipino Female: A Case Report
D3.58 - Drug-Induced Enterocolitis Syndrome (DIES) Associated to Amoxicillin and Amoxicillin-Clavulanic Acid: A Growing Concern at a Tertiary Hospital
D3.59 - Insights from Drug Provocation Testing in Quinolone Allergy
D3.60 - Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
D3.62 - Beta-Lactam Hypersensitivity: 5-year characterization of patients evaluated at the University of Chile Clinical Hospital
D3.63 - 5 Year Follow Up: Unveiling True Beta-Lactam Immediate Hypersensitivity in the University of Chile Clinical Hospital
D3.364 - Effect of Omalizumab on Inflammatory and Immune Biomarkers in Mast Cell-Mediated Angioedema
D3.358 - The impact of limited access to On-Demand Treatment for Hereditary Angioedema on Quality of life: a comparison between two income settings
D3.359 - Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment
D3.362 - Use and safety of canakinumab during pregnancy
D3.363 - Vitamin D3 deficiency promotes epithelial-to-mesenchymal transition and thus favours pulmonary fibrosis development in the murine model of hypersensitivity pneumonitis
Pagination
Current page
1
Page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download